Research Article
Mucormycosis Secondary to Coronavirus Disease A Case Series from a Tertiary Care Hospital in Maharashtra
Author(s): Rahul T Thakur*, Kirti Salunke, Anand Meher, Vaibhav Madane and Keshav Zargad
Background: As the pandemic of Coronavirus disease (COVID-19) progresses, health care remains a new challenge. The recent rise in second wave possess a different challenge of opportunistic infections especially mucormycosis in COVID-19 recovered patients. It is complicating their future outcomes and making quality of life more morbid. Mucormycosis was well known to infect patients with immunocompromised conditions, as the treatment of COVID-19 largely rests on systemic steroids and other immunosuppressant’s the risk of invasive fungal infection has increased.
Methodology: Here, we present a case series of 07 patients with individual clinical characteristics along with the demography and treatment details studied during 3 months June 2021 to August 2021. The data was collected in a single center that caters to a large population of COVI.. Read More»
Select your language of interest to view the total content in your interested language